Open AccessThe role of calcium antagonists in the treatment of cardiovascular disease: Focus on diltiazem
Author(s) -
Г. А. Барышникова,
S A Chorbinskaya,
I I Stepanova
Publication year - 2015
Publication title -
cardiosomatika
Language(s) - English
Resource type - Journals
eISSN - 2658-5707
pISSN - 2221-7185
DOI - 10.26442/cs45175
Subject(s) - diltiazem , medicine , tolerability , angina , cardiology , calcium , left ventricular hypertrophy , adverse effect , blood pressure , myocardial infarction
The article deals with the use of calcium antagonists (CA) with a focus on diltiazem for the treatment of hypertension, angina pectoris, and cardiac arrhythmias, for secondary prevention of coronary heart disease, to evaluate their cardiac, angiography, nephroprotective effect, the ability to prevent the development of left ventricular hypertrophy. The problems of tolerability and safety of CA in short and prolonged action.